Methylcobalamin may be considered under specialist supervision, but this is a decision for an ophthalmologist and internist not a med spa aesthetician
Because human safety data are still limited and BPC-157 is not FDA-approved, patient selection matters
At Spectrum Healthcare, we are committed to leading in integrative medicine research and providing our patients with the most current, honest, and balanced advice available
Patients should be aware that: No licensed combination product exists in the UK Any combination use would be considered experimental and is not supported by current evidence Clinical decisions must be guided by a qualified healthcare professional with access to current trial data Clinical Evidence and Trial Data Available to UK Patients Retatrutide Phase 2 data showed approximately 24% mean body weight reduction at the highest dose over 48 weeks, but no published trial data exist for the specific cagrilintideretatrutide combination
B12 (cobalamin) is water-soluble
If you've administered more than the prescribed dose, inform your doctor promptly